Magnetic resonance imaging of the natural history of in situmammary neoplasia in transgenic mice: a pilot study
Open Access
- 4 September 2009
- journal article
- Published by Springer Nature in Breast Cancer Research
- Vol. 11 (5) , R65
Abstract
Introduction: Because of the small size of in situ mammary cancers in mouse models, high-resolution imaging techniques are required to effectively observe how lesions develop, grow and progress over time. The purpose of this study was to use magnetic resonance (MR) imaging to track in vivo the transition from in situ neoplasia to invasive cancer in a transgenic mouse model of human cancer. Methods: MR images of 12 female C3(1) SV40 Tag mice that develop mammary intraepithelial neoplasia (MIN) were obtained. MIN is believed to be similar to human ductal carcinoma in situ (DCIS) and is considered a precursor of invasive tumors. Images were serially obtained from 10-21 weeks of age at 2-3 week intervals. MIN lesions were identified based on their morphology on MR images. Lesions were followed over time and several lesion features were measured including volume, growth rate and morphology. For those MIN lesions that progressed to invasive cancer the progression time was measured. Results: Overall, 21 MIN lesions were initially detected at an average initial volume of 0.3 ± 0.2 mm3 with an average growth rate of -0.15 ± 0.66 week-1. Even though all mice were inbred to express the SV40 Tag transgene in the mammary epithelium and expected to develop invasive carcinoma, the individual MIN lesions took vastly different progression paths: (i) 9 lesions progressed to invasive tumors with an average progression time of 4.6 ± 1.9 weeks; (ii) 2 lesions regressed, i.e., were not detected on future images; and (iii) 5 were stable for over 8 weeks, and were demonstrated by a statistical model to represent indolent disease. Conclusions: To our knowledge, the results reported here are the first measurements of the timescale and characteristics of progression from in situ neoplasia to invasive carcinoma and provide image-based evidence that DCIS may be a non-obligate precursor lesion with highly variable outcomes. In addition, this study represents a first step towards developing methods of image acquisition for identifying radiological characteristics that might predict which in situ neoplasias will become invasive cancers and which are unlikely to progress.Keywords
This publication has 46 references indexed in Scilit:
- Ductal Carcinoma in Situ: X-ray Fluorescence Microscopy and Dynamic Contrast-enhanced MR Imaging Reveals Gadolinium Uptake within Neoplastic Mammary Ducts in a Murine ModelRadiology, 2009
- Spontaneous Regression of a Breast Carcinoma: A Case ReportGynecologic and Obstetric Investigation, 2007
- Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green teaBreast Cancer Research and Treatment, 2007
- The natural history of ductal carcinoma in situ of the breast: a reviewBreast Cancer Research and Treatment, 2005
- Oncolytic Herpes Simplex Virus Vector Therapy of Breast Cancer in C3(1)/SV40 T-antigen Transgenic MiceCancer Research, 2005
- Mathematical modelling of comedo ductal carcinoma in situ of the breastMathematical Medicine and Biology: A Journal of the IMA, 2003
- The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the diseaseEuropean Journal of Cancer, 2003
- Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatinInternational Journal of Cancer, 2002
- A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective studyThe Lancet, 2000
- Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic miceOncogene, 1998